Literature DB >> 21179014

Metabonomic, transcriptomic, and genomic variation of a population cohort.

Michael Inouye1, Johannes Kettunen, Pasi Soininen, Kaisa Silander, Samuli Ripatti, Linda S Kumpula, Eija Hämäläinen, Pekka Jousilahti, Antti J Kangas, Satu Männistö, Markku J Savolainen, Antti Jula, Jaana Leiviskä, Aarno Palotie, Veikko Salomaa, Markus Perola, Mika Ala-Korpela, Leena Peltonen.   

Abstract

Comprehensive characterization of human tissues promises novel insights into the biological architecture of human diseases and traits. We assessed metabonomic, transcriptomic, and genomic variation for a large population-based cohort from the capital region of Finland. Network analyses identified a set of highly correlated genes, the lipid-leukocyte (LL) module, as having a prominent role in over 80 serum metabolites (of 134 measures quantified), including lipoprotein subclasses, lipids, and amino acids. Concurrent association with immune response markers suggested the LL module as a possible link between inflammation, metabolism, and adiposity. Further, genomic variation was used to generate a directed network and infer LL module's largely reactive nature to metabolites. Finally, gene co-expression in circulating leukocytes was shown to be dependent on serum metabolite concentrations, providing evidence for the hypothesis that the coherence of molecular networks themselves is conditional on environmental factors. These findings show the importance and opportunity of systematic molecular investigation of human population samples. To facilitate and encourage this investigation, the metabonomic, transcriptomic, and genomic data used in this study have been made available as a resource for the research community.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21179014      PMCID: PMC3018170          DOI: 10.1038/msb.2010.93

Source DB:  PubMed          Journal:  Mol Syst Biol        ISSN: 1744-4292            Impact factor:   13.068


  36 in total

Review 1.  Inflammation and metabolic disorders.

Authors:  Gökhan S Hotamisligil
Journal:  Nature       Date:  2006-12-14       Impact factor: 49.962

Review 2.  The role of protein glycosylation in allergy.

Authors:  Friedrich Altmann
Journal:  Int Arch Allergy Immunol       Date:  2006-10-09       Impact factor: 2.749

Review 3.  An overview of reverse cholesterol transport.

Authors:  A R Tall
Journal:  Eur Heart J       Date:  1998-02       Impact factor: 29.983

4.  Identification of unique lipoprotein subclasses for visceral obesity by component analysis of cholesterol profile in high-performance liquid chromatography.

Authors:  Mitsuyo Okazaki; Shinichi Usui; Masato Ishigami; Naohiko Sakai; Tadashi Nakamura; Yuji Matsuzawa; Shizuya Yamashita
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-01-06       Impact factor: 8.311

5.  Genetics of gene expression and its effect on disease.

Authors:  Valur Emilsson; Gudmar Thorleifsson; Bin Zhang; Amy S Leonardson; Florian Zink; Jun Zhu; Sonia Carlson; Agnar Helgason; G Bragi Walters; Steinunn Gunnarsdottir; Magali Mouy; Valgerdur Steinthorsdottir; Gudrun H Eiriksdottir; Gyda Bjornsdottir; Inga Reynisdottir; Daniel Gudbjartsson; Anna Helgadottir; Aslaug Jonasdottir; Adalbjorg Jonasdottir; Unnur Styrkarsdottir; Solveig Gretarsdottir; Kristinn P Magnusson; Hreinn Stefansson; Ragnheidur Fossdal; Kristleifur Kristjansson; Hjortur G Gislason; Tryggvi Stefansson; Bjorn G Leifsson; Unnur Thorsteinsdottir; John R Lamb; Jeffrey R Gulcher; Marc L Reitman; Augustine Kong; Eric E Schadt; Kari Stefansson
Journal:  Nature       Date:  2008-03-16       Impact factor: 49.962

6.  Effect of combinations of cytokines and hormones on synthesis of serum amyloid A and C-reactive protein in Hep 3B cells.

Authors:  M K Ganapathi; D Rzewnicki; D Samols; S L Jiang; I Kushner
Journal:  J Immunol       Date:  1991-08-15       Impact factor: 5.422

Review 7.  Minireview: adiposity, inflammation, and atherogenesis.

Authors:  Christopher J Lyon; Ronald E Law; Willa A Hsueh
Journal:  Endocrinology       Date:  2003-06       Impact factor: 4.736

8.  Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women.

Authors:  Samia Mora; James D Otvos; Nader Rifai; Robert S Rosenson; Julie E Buring; Paul M Ridker
Journal:  Circulation       Date:  2009-02-09       Impact factor: 29.690

9.  Interleukin-1-receptor antagonist in type 2 diabetes mellitus.

Authors:  Claus M Larsen; Mirjam Faulenbach; Allan Vaag; Aage Vølund; Jan A Ehses; Burkhardt Seifert; Thomas Mandrup-Poulsen; Marc Y Donath
Journal:  N Engl J Med       Date:  2007-04-12       Impact factor: 91.245

10.  A genotype calling algorithm for the Illumina BeadArray platform.

Authors:  Yik Y Teo; Michael Inouye; Kerrin S Small; Rhian Gwilliam; Panagiotis Deloukas; Dominic P Kwiatkowski; Taane G Clark
Journal:  Bioinformatics       Date:  2007-09-10       Impact factor: 6.937

View more
  116 in total

Review 1.  Metabolomics as a tool for cardiac research.

Authors:  Julian L Griffin; Helen Atherton; John Shockcor; Luigi Atzori
Journal:  Nat Rev Cardiol       Date:  2011-09-20       Impact factor: 32.419

Review 2.  Integrated metabolomics and genomics: systems approaches to biomarkers and mechanisms of cardiovascular disease.

Authors:  Svati H Shah; Christopher B Newgard
Journal:  Circ Cardiovasc Genet       Date:  2015-04

3.  Modeling of pathological traits in Alzheimer's disease based on systemic extracellular signaling proteome.

Authors:  Markus Britschgi; Kaspar Rufibach; Sarah L Bauer Huang; Christopher M Clark; Jeffrey A Kaye; Ge Li; Elaine R Peskind; Joseph F Quinn; Douglas R Galasko; Tony Wyss-Coray
Journal:  Mol Cell Proteomics       Date:  2011-07-08       Impact factor: 5.911

Review 4.  Genetic variation in metabolic phenotypes: study designs and applications.

Authors:  Karsten Suhre; Christian Gieger
Journal:  Nat Rev Genet       Date:  2012-10-03       Impact factor: 53.242

5.  A sulfur amino acid-free meal increases plasma lipids in humans.

Authors:  Youngja Park; Ngoc-Anh Le; Tianwei Yu; Fred Strobel; Nana Gletsu-Miller; Carolyn J Accardi; Kichun S Lee; Shaoxiong Wu; Thomas R Ziegler; Dean P Jones
Journal:  J Nutr       Date:  2011-06-15       Impact factor: 4.798

6.  High-performance metabolic profiling of plasma from seven mammalian species for simultaneous environmental chemical surveillance and bioeffect monitoring.

Authors:  Youngja H Park; Kichun Lee; Quinlyn A Soltow; Frederick H Strobel; Kenneth L Brigham; Richard E Parker; Mark E Wilson; Roy L Sutliff; Keith G Mansfield; Lynn M Wachtman; Thomas R Ziegler; Dean P Jones
Journal:  Toxicology       Date:  2012-03-01       Impact factor: 4.221

7.  Analyzing LC/MS metabolic profiling data in the context of existing metabolic networks.

Authors:  Tianwei Yu; Yun Bai
Journal:  Curr Metabolomics       Date:  2013-01-01

8.  Insomnia does not mediate or modify the association between MTNR1B risk variant rs10830963 and glucose levels.

Authors:  Hanna M Ollila; Erkki Kronholm; Johannes Kettunen; Kaisa Silander; Markus Perola; Tarja Porkka-Heiskanen; Veikko Salomaa; Tiina Paunio
Journal:  Diabetologia       Date:  2016-02-24       Impact factor: 10.122

9.  Novel association of TM6SF2 rs58542926 genotype with increased serum tyrosine levels and decreased apoB-100 particles in Finns.

Authors:  Daniel Seung Kim; Anne U Jackson; Yatong K Li; Heather M Stringham; Johanna Kuusisto; Antti J Kangas; Pasi Soininen; Mika Ala-Korpela; Charles F Burant; Veikko Salomaa; Michael Boehnke; Markku Laakso; Elizabeth K Speliotes
Journal:  J Lipid Res       Date:  2017-05-24       Impact factor: 5.922

10.  Exploring the Process of Energy Generation in Pathophysiology by Targeted Metabolomics: Performance of a Simple and Quantitative Method.

Authors:  Marta Riera-Borrull; Esther Rodríguez-Gallego; Anna Hernández-Aguilera; Fedra Luciano; Rosa Ras; Elisabet Cuyàs; Jordi Camps; Antonio Segura-Carretero; Javier A Menendez; Jorge Joven; Salvador Fernández-Arroyo
Journal:  J Am Soc Mass Spectrom       Date:  2015-09-17       Impact factor: 3.109

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.